173 related articles for article (PubMed ID: 10573070)
1. Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome.
Ishikawa A; Flechner SM; Goldfarb DA; Myles JL; Modlin CS; Boparai N; Papajcik D; Mastroianni B; Novick AC
Transplantation; 1999 Nov; 68(9):1318-24. PubMed ID: 10573070
[TBL] [Abstract][Full Text] [Related]
2. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
3. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
[TBL] [Abstract][Full Text] [Related]
4. Impact of Banff borderline acute rejection among renal allograft recipients.
Matoza JR; Danguilan RA; Chicano S
Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
[TBL] [Abstract][Full Text] [Related]
5. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
6. Impact of acute rejection and early allograft function on renal allograft survival.
Cosio FG; Pelletier RP; Falkenhain ME; Henry ML; Elkhammas EA; Davies EA; Bumgardner GL; Ferguson RM
Transplantation; 1997 Jun; 63(11):1611-5. PubMed ID: 9197355
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
[TBL] [Abstract][Full Text] [Related]
8. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
[TBL] [Abstract][Full Text] [Related]
9. Predictors of renal transplant histology at three months.
Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
[TBL] [Abstract][Full Text] [Related]
10. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.
Flechner SM; Modlin CS; Serrano DP; Goldfarb DA; Papajcik D; Mastroianni B; Goormastic M; Novick AC
Transplantation; 1996 Nov; 62(9):1235-41. PubMed ID: 8932263
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
12. Effect of initial slow graft function on renal allograft rejection and survival.
Humar A; Johnson EM; Payne WD; Wrenshall L; Sutherland DE; Najarian JS; Gillingham KJ; Matas AJ
Clin Transplant; 1997 Dec; 11(6):623-7. PubMed ID: 9408697
[TBL] [Abstract][Full Text] [Related]
13. Role of protocol biopsy in early graft dysfunction in renal transplant recipient.
Islam SF; Hadiuzzaman KM; Islam MN; Khanam A; Faroque MO; Ahmed AH
Mymensingh Med J; 2014 Apr; 23(2):286-9. PubMed ID: 24858156
[TBL] [Abstract][Full Text] [Related]
14. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
[TBL] [Abstract][Full Text] [Related]
16. Features of acute rejection that increase risk for chronic rejection.
Humar A; Kerr S; Gillingham KJ; Matas AJ
Transplantation; 1999 Oct; 68(8):1200-3. PubMed ID: 10551652
[TBL] [Abstract][Full Text] [Related]
17. Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology.
Cosio FG; Pelletier RP; Sedmak DD; Pesavento TE; Henry ML; Ferguson RM
Kidney Int; 1999 Nov; 56(5):1912-9. PubMed ID: 10571802
[TBL] [Abstract][Full Text] [Related]
18. [Effect of recipient age on the clinical course of renal transplantation].
Palomar R; Ruiz JC; Cotorruelo JG; Zubimendi JA; de Francisco AL; Rodrigo E; Sanz S; Arias M
Nefrologia; 2001; 21(4):386-91. PubMed ID: 11816515
[TBL] [Abstract][Full Text] [Related]
19. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
[TBL] [Abstract][Full Text] [Related]
20. OKT3 for primary therapy of the first rejection episode in kidney transplants.
Tesi RJ; Elkhammas EA; Henry ML; Ferguson RM
Transplantation; 1993 May; 55(5):1023-9. PubMed ID: 8497875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
